Approval in the UK should end this argument, once that occurs the other regulators should fall in line, but it may wait for the EDEN unit to be accepted for commercial production. People who criticize the the trial fail to realize how much was learned, and how much the regulators became involved in redesigning it to look at OS and ignore the PFS goals flawed by pseudoprogression.